Stocks Overview

LAST PRICE
27.3700
TODAY'S CHANGE (%)
Trending Down-0.7300 (-2.5979%)

Bid / Lots
27.1300/ 1
Ask / Lots
28.4800/ 1
Open / Previous Close
28.2400 / 28.1000
Day Range
Low 27.3500
High 28.2650
52 Week Range
Low 22.0100
High 32.8800
Volume
1,560,576
below average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TSX Comp
TSX Venture
DJIA
S&P 500
NASDAQ

Price Comparison Graph. See accessible table below

1 Day Comparison Chart Accessibility Table. Monday's close: 28.1
Time	Volume	ALKS
09:32 ET	10552	28.265
09:34 ET	400	28.125
09:36 ET	300	27.98
09:38 ET	1025	28.05
09:39 ET	1300	28.095
09:41 ET	503	28.04
09:43 ET	2204	27.97
09:45 ET	900	27.98
09:48 ET	200	27.95
09:50 ET	800	27.83
09:52 ET	2575	27.86
09:54 ET	772	27.7408
09:56 ET	1800	27.77
09:57 ET	644	27.745
09:59 ET	1100	27.75
10:01 ET	1475	27.7
10:03 ET	300	27.71
10:06 ET	1362	27.69
10:08 ET	500	27.68
10:10 ET	606	27.67
10:12 ET	560	27.65
10:14 ET	2400	27.68
10:15 ET	1091	27.615
10:17 ET	1273	27.635
10:19 ET	600	27.64
10:21 ET	1977	27.652
10:24 ET	2055	27.7
10:26 ET	652	27.7
10:28 ET	1765	27.65
10:30 ET	3116	27.58
10:32 ET	3999	27.53
10:33 ET	2071	27.58
10:35 ET	1574	27.56
10:37 ET	800	27.51
10:39 ET	2292	27.46
10:42 ET	2921	27.48
10:44 ET	700	27.47
10:46 ET	900	27.465
10:48 ET	1120	27.48
10:50 ET	1200	27.48
10:51 ET	1000	27.475
10:53 ET	700	27.42
10:55 ET	1316	27.43
10:57 ET	991	27.46
11:00 ET	600	27.46
11:02 ET	600	27.44
11:04 ET	1800	27.41
11:06 ET	924	27.4
11:08 ET	823	27.41
11:09 ET	917	27.41
11:11 ET	1908	27.42
11:13 ET	2900	27.43
11:15 ET	600	27.405
11:18 ET	952	27.44
11:20 ET	1308	27.46
11:22 ET	627	27.45
11:24 ET	1318	27.46
11:26 ET	300	27.415
11:27 ET	1355	27.41
11:29 ET	2858	27.45
11:31 ET	200	27.46
11:33 ET	992	27.48
11:36 ET	200	27.49
11:38 ET	626	27.47
11:40 ET	1028	27.46
11:42 ET	634	27.46
11:45 ET	1000	27.44
11:47 ET	928	27.445
11:49 ET	602	27.4354
11:51 ET	1494	27.43
11:54 ET	600	27.45
11:56 ET	809	27.475
11:58 ET	200	27.47
12:00 ET	800	27.435
12:02 ET	800	27.425
12:03 ET	678	27.43
12:05 ET	300	27.435
12:07 ET	801	27.46
12:09 ET	1780	27.44
12:12 ET	500	27.45
12:14 ET	300	27.44
12:16 ET	1980	27.405
12:18 ET	854	27.4
12:20 ET	1128	27.435
12:21 ET	275	27.426074
12:23 ET	2179	27.4444
12:25 ET	500	27.41
12:27 ET	820	27.42
12:30 ET	1895	27.405
12:32 ET	870	27.44
12:34 ET	700	27.43
12:36 ET	656	27.44
12:38 ET	300	27.42
12:39 ET	712	27.44
12:41 ET	600	27.42
12:43 ET	100	27.42
12:45 ET	900	27.39
12:48 ET	576	27.39
12:50 ET	922	27.39
12:52 ET	1830	27.35
12:54 ET	100	27.365
12:56 ET	1009	27.37
12:57 ET	804	27.37
12:59 ET	300	27.365
01:01 ET	100	27.36
01:03 ET	100	27.36
01:06 ET	500	27.38
01:08 ET	700	27.38
01:10 ET	781	27.38
01:12 ET	200	27.38
01:14 ET	2474	27.39
01:15 ET	200	27.38
01:17 ET	400	27.38
01:19 ET	500	27.38
01:21 ET	400	27.38
01:24 ET	700	27.38
01:26 ET	736	27.42
01:28 ET	300	27.42
01:30 ET	1300	27.41
01:32 ET	609	27.385
01:33 ET	500	27.38
01:35 ET	733	27.38
01:37 ET	1593	27.37
01:39 ET	670	27.36
01:42 ET	3410	27.37
01:44 ET	2200	27.37
01:46 ET	1032	27.365
01:48 ET	600	27.38
01:50 ET	1000	27.42
01:51 ET	1100	27.395
01:53 ET	1000	27.4
01:55 ET	500	27.42
01:57 ET	500	27.43
02:00 ET	2075	27.38
02:02 ET	1535	27.37
02:04 ET	2020	27.37
02:06 ET	1371	27.37
02:08 ET	2174	27.38
02:09 ET	2055	27.41
02:11 ET	879	27.4
02:13 ET	1484	27.41
02:15 ET	1788	27.4
02:18 ET	3188	27.395
02:20 ET	3424	27.37
02:22 ET	1550	27.38
02:24 ET	1971	27.39
02:26 ET	1018	27.38
02:27 ET	1804	27.395
02:29 ET	1300	27.375
02:31 ET	1975	27.38
02:33 ET	1798	27.395
02:36 ET	2306	27.4
02:38 ET	2482	27.415
02:40 ET	1795	27.4
02:42 ET	1596	27.41
02:44 ET	1400	27.405
02:45 ET	4521	27.44
02:47 ET	4229	27.46
02:49 ET	1500	27.46
02:51 ET	3249	27.48
02:54 ET	2925	27.475
02:56 ET	3021	27.475
02:58 ET	1600	27.475
03:00 ET	7212	27.52
03:02 ET	2142	27.515
03:03 ET	2527	27.53
03:05 ET	1500	27.54
03:07 ET	3833	27.54
03:09 ET	2381	27.54
03:12 ET	1867	27.55
03:14 ET	2945	27.55
03:16 ET	122565	27.59
03:18 ET	3702	27.58
03:20 ET	1726	27.56
03:21 ET	55853	27.7
03:23 ET	8233	27.65
03:25 ET	4681	27.61
03:27 ET	4456	27.6
03:30 ET	5100	27.625
03:32 ET	2200	27.59
03:34 ET	6278	27.55
03:36 ET	3842	27.515
03:38 ET	2376	27.53
03:39 ET	3340	27.545
03:41 ET	2818	27.52
03:43 ET	8889	27.51
03:45 ET	5733	27.51
03:48 ET	4106	27.51
03:50 ET	6436	27.46
03:52 ET	6045	27.435
03:54 ET	6817	27.444
03:56 ET	22743	27.48
03:57 ET	20001	27.415
03:59 ET	346867	27.37

Data delayed at least 15 minutes.

Yesterday
- Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024, from 7:00AM ET on Monday Sep 23, 2024 by Dow Jones
  7:00AM ET on Monday Sep 23, 2024 by Dow Jones
Sep 16, 2024
- DJ Alkermes Price Target Maintained With a $48.00/Share by Cantor Fitzgerald, from 11:30AM ET on Monday Sep 16, 2024 by Dow Jones
  11:30AM ET on Monday Sep 16, 2024 by Dow Jones
Sep 13, 2024
- Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards(R) Program, from 7:00AM ET on Friday Sep 13, 2024 by Dow Jones
  7:00AM ET on Friday Sep 13, 2024 by Dow Jones
Aug 28, 2024
- Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 4:00PM ET on Wednesday Aug 28, 2024 by Dow Jones
  4:00PM ET on Wednesday Aug 28, 2024 by Dow Jones

0 New Today

Industry Peers Overview Table
Company sortable	Market Cap sortable	P/E Ratio (TTM) sortable	EPS Growth (5yr) sortable
United StatesALKS Alkermes Plc	4.6B	10.2x	---
United StatesEXEL Exelixis Inc	7.5B	22.5x	-21.77%
United StatesPTCT PTC Therapeutics Inc	2.8B	-5.8x	---
United StatesNVAX Novavax Inc	2.0B	-4.8x	---
United StatesPIII P3 Health Partners Inc	139.3M	-0.7x	---
United StatesQGEN Qiagen NV	10.0B	141.0x	+12.66%
As of 2024-09-24

Alkermes plc is a global biopharmaceutical company that seeks to develop medicines in the field of neuroscience. The Company has a portfolio of commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. It focuses on commercial products, such as LYBALVI, ARISTADA/ARISTADA INITIO and VIVITROL, and advancing the development of pipeline programs focused on neurological disorders. LYBALVI is a once-daily, oral atypical antipsychotic drug for the treatment of adults with schizophrenia and for the treatment of adults with bipolar I disorder, as a maintenance monotherapy or for the acute treatment of manic or mixed episodes, as monotherapy or an adjunct to lithium or valproate. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia. It has a manufacturing facility in Wilmington, Ohio.

Contact Information

Headquarters: Connaught House 1 Burlington Road, Dublin 4DUBLIN, Ireland D04 C5Y6
Phone: ---
Fax: ---

Executives

Chairman of the Board, Chief Executive Officer: Richard Pops
Interim Chief Financial Officer, Chief Operating Officer, Executive Vice President, Interim Chief Accounting Officer, Chief Risk Officer: Blair Jackson
Executive Vice President, Chief Compliance Officer, Chief Legal Officer, Secretary: David Gaffin
Executive Vice President, Research and Development and Chief Medical Officer: Craig Hopkinson
Senior Vice President, Chief Commercial Officer: C.Todd Nichols

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Skip section

INK Company InsiderDetailed daily analysis of insider activity and holdings for stocks and income trusts listed in Canada, based on filings from SEDI®.

Fundamentals Table
Market Cap	$4.6B
Revenue (TTM)	$1.5B
Shares Outstanding	164.7M
Dividend Yield	0.00%
Annual Dividend Rate	---
Ex-Dividend Date	01-01-01
Pay Date	01-01-01
Beta	0.42
EPS	$2.67
Book Value	$7.20
P/E Ratio	10.2x
Price/Sales (TTM)	3.1
Price/Cash Flow (TTM)	9.1x
Operating Margin	24.91%

*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.

Alkermes Plc
NASDAQ:ALKSUnited States

Search Criteria

Charts

Recent News

Yesterday

Alkermes to Present Positive Clinical Data From Phase 1b Study of ALKS 2680 in Patients With Narcolepsy Type 2 and Idiopathic Hypersomnia at Sleep Europe 2024, from 7:00AM ET on Monday Sep 23, 2024 by Dow Jones

Sep 16, 2024

DJ Alkermes Price Target Maintained With a $48.00/Share by Cantor Fitzgerald, from 11:30AM ET on Monday Sep 16, 2024 by Dow Jones

Sep 13, 2024

Alkermes Announces Launch of 7th Annual Alkermes Pathways Research Awards(R) Program, from 7:00AM ET on Friday Sep 13, 2024 by Dow Jones

Aug 28, 2024

Alkermes to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference, from 4:00PM ET on Wednesday Aug 28, 2024 by Dow Jones

Biotechnology Industry Peers

Company Information

Contact Information

Executives

Ratings

Reports

Fundamentals

Calendar